erythromycin has been researched along with oprozomib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, X; Gao, L; Hu, X; Hu, Y; Li, D; Li, J; Liu, T; Ma, X; Xu, L; Yu, J; Zhang, J; Zhang, X; Zhou, Y | 1 |
1 other study(ies) available for erythromycin and oprozomib
Article | Year |
---|---|
Development of Macrocyclic Peptides Containing Epoxyketone with Oral Availability as Proteasome Inhibitors.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Humans; Ketones; Macrocyclic Compounds; Mice; Peptides; Permeability; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Conformation; Tissue Distribution | 2018 |